Onena Medicines
Biotechnology Research • 
Allschwil, Basel-Country, Switzerland • 1-10 Employees
Company overview
| Headquarters | Gewerbestrasse 24, Switzerland Innovation Park Basel Area AG, Basel, Switzerland 4123, CH |
| Website | |
| Keywords | Biotechnology, Cancer, Clinical Trial, Rare Diseases, Clinical, Switzerland, Oncology, Drug Development, Drug Discovery, Basel, Biologics, Spain, Antibody Engineering, Patient, Assay |
| Founded | 2019 |
| Employees | 1-10 |
| Socials |
Key Contact at Onena Medicines
Neethan Lobo
Ceo And Co-Founder
Onena Medicines Email Formats
Onena Medicines uses 2 email formats. The most common is {first name} (e.g., john@onenameds.com), used 57.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@onenameds.com | 57.1% |
{first initial} | j@onenameds.com | 42.9% |
About Onena Medicines
Onena Medicines is a biopharmaceutical company with a pipeline of first-in-class antibody medicines to treat recurrent and metastatic cancers and selected rare diseases. Onena’s drugs neutralize a new class of secreted ancient growth factors, conserved across species, called Dual SMAD Inhibiting Proteins (DSIPs), that program cancer cells to grow and resist chemotherapy. Blocking DSIPs, as demonstrated in-vivo by Onena, simultaneously reactivates physiological TGF-β and BMP signaling and elicits cellular reprogramming, resulting in cancer cells accepting environmental cell death signals from BMPs and Activins. Onena has developed a proprietary AI-centric antibody drug discovery platform that rapidly generates anti-DSIP neutralizing antibodies, even when no crystal structure of the antigen is available. OMED-101, Onena’s anti-LEFTY1/2 lead candidate antibody, has demonstrated broad efficacy against breast, colorectal and brain cancers without observable toxicities in preclinical models. Through its unique platform, Onena Medicines has discovered several DSIPs and aims to advance multiple neutralizing DSIP antibody drugs into clinical development in the next three years.
Onena Medicines revenue & valuation
| Annual revenue | $2,100,000 |
| Revenue per employee | $210,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $6,800,000 |
| Total funding | $4,099,999 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Onena Medicines has 3 employees across 3 departments.
Departments
Number of employees
Onena Medicines Tech Stack
Discover the technologies and tools that power Onena Medicines's digital infrastructure, from frameworks to analytics platforms.
Font scripts
JavaScript libraries
JavaScript libraries
Security
Ecommerce
JavaScript frameworks
Security
Miscellaneous
JavaScript libraries
Ecommerce
Maps
JavaScript libraries
United States
Slovenia
United Kingdom
CanadaFrequently asked questions
4.8
40,000 users
